On 2/19/18 Kaleido Biosciences filed for a $120 Million IPO. The company will offer 4,761,905 shares of common stock. The expected price is between $20 and $22 per share. The shares will be... read more
On 2/19/18 Kaleido Biosciences filed for a $120 Million IPO. The company will offer 4,761,905 shares of common stock. The expected price is between $20 and $22 per share. The shares will be... read more
CStone Pharmaceuticals is seeking to raise $282 Million in its upcoming Hong Kong IPO. The company's investors include Boyu Capital, Sequoia Capital, Oriza Holdings, and GIC.
The company... read more
5AM Venture Management, LLC (5AM) of San Francisco, CA and Boston, MA announced on 2/13/19 the closing of two new venture capital funds, totaling $497 million in committed capital. The capital was... read more
Cirius Therapeutics has updated it filing for a planned $86 million IPO. The date of the IPO still hasn't been set.
Cirius' lead candidate, MSDC-0602K, is a once daily, oral treatment for... read more
Ascletis Pharma Inc. (Ascletis, 1672.HK) and 3-V Biosciences, Inc. (3-V Biosciences) jointly announced on 2/13/19 that Ascletis, through its subsidiary, and 3-V Biosciences have entered into an... read more